Review




Structured Review

CellPro Inc cd34+ fraction
Cd34+ Fraction, supplied by CellPro Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd34++fraction/anti+cd34+matrix+column/us07115267-820-13-22
Average 90 stars, based on 1 article reviews
cd34+ fraction - by Bioz Stars, 2026-09
90/100 stars

Images

Related Articles

other:

Article Title: Human facilitating cells
Article Snippet: No. 5,061,620 or the LC Laboratory Cell Separation System, CD34 Kit (CellPro, Inc., Bothell, Wash.).

Article Title: Ex vivo T-cell-depleted allogeneic stem cell transplantation for hematologic malignancies: The search for an optimum transplant T-cell dose and T-cell add-back strategy.
Article Snippet: Background.. T-cell depletion (TCD) of allogeneic stem cell transplants (SCT) can reduce graft-versus-host disease but may negatively affect transplant outcome by delaying immune recovery.. To optimize TCD in HLA-matched siblings with hematologic malignancies, we explored varying the transplant CD3+ T-cell dose between 2 and 50 × 10/kg (corresponding to 3–4 log depletion) and studied the impact of 0–6 × 10/kg CD3+ donor lymphocyte infusion (DLI) “add-back” on immune recovery post-SCT.

Article Title: Improved collection of hematopoietic stem cells and progenitors from Fanconi anemia patients for gene therapy purposes
Article Snippet: La purificación de las células CD34+ se realizó con el sistema CellPro.

Article Title: Method for enucleating nucleated erythrocyte, and enucleation inducer
Article Snippet: Most widely utilized is a positive immunological selection based on binding the cell to an anti-CD34 antibody (Cellpro, Baxter, Myltenyi) immobilized on a solid support.

Article Title: RANK ligand polypeptides
Article Snippet: Briefly, human BM cells from normal healthy volunteers were density fractionated using Ficoll medium and CD34+ cells immunoaffinity isolated using an anti-CD34 matrix column (Ceprate, CellPro).

Article Title: Receptor activator of NF-kappaB
Article Snippet: Briefly, human BM cells from normal healthy volunteers were density fractionated using Ficoll medium and CD34+cells immunoaffinity isolated using an anti-CD34 matrix column (Ceprate, CellPro).

Article Title: Method for producing red blood cells
Article Snippet: The most widely used is a positive immunological selection based on binding of these cells to anti-CD34-antibodies immobilized on a solid support (Cellpro, Baxter, Myltenyi).

Selection:

Article Title: Five year follow-up after autologous peripheral blood hematopoietic stem cell transplantation for refractory, chronic, corticosteroid-dependent systemic lupus erythematosus: effect of conditioning regimen on outcome.
Article Snippet: .. Subsequently, due to the inability to obtain CD34 columns from American manufacturers (Cellpro Inc, Seattle, Washington, or Baxter International, Deerfield, Illinois), we developed a regimen using alemtuzumab and the same dose of cyclophosphamide without CD34 selection. ..



Similar Products

96
Miltenyi Biotec cd34 fraction
Cd34 Fraction, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd34++fraction/CD34+MicroBead+Kit+UltraPure%2C+human/bio_rxiv__64898__2025__12__22__695871-246-1-6
Average 96 stars, based on 1 article reviews
cd34 fraction - by Bioz Stars, 2026-09
96/100 stars
  Buy from Supplier

99
Miltenyi Biotec cd34 cell fractions
Cd34 Cell Fractions, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd34++fraction/CD34-VioBlue/us12203096-489-17-31
Average 99 stars, based on 1 article reviews
cd34 cell fractions - by Bioz Stars, 2026-09
99/100 stars
  Buy from Supplier

99
Miltenyi Biotec cd34 cell fraction
Cd34 Cell Fraction, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd34++fraction/CD34-VioBlue/pm39277669-53-1-17
Average 99 stars, based on 1 article reviews
cd34 cell fraction - by Bioz Stars, 2026-09
99/100 stars
  Buy from Supplier

99
Qiagen cd34 cell fraction
Cd34 Cell Fraction, supplied by Qiagen, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd34++fraction/miRNeasy+Micro+Kit/pmc11604037-358-7-18
Average 99 stars, based on 1 article reviews
cd34 cell fraction - by Bioz Stars, 2026-09
99/100 stars
  Buy from Supplier

90
Glaxo Smith autologous cd34+-enriched cell fraction strimvelis
FDA/EMA approved gene therapy product for rare monogenic diseases
Autologous Cd34+ Enriched Cell Fraction Strimvelis, supplied by Glaxo Smith, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd34++fraction/strimvelis/pmc11222908-222-7-8
Average 90 stars, based on 1 article reviews
autologous cd34+-enriched cell fraction strimvelis - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

Image Search Results


FDA/EMA approved gene therapy product for rare monogenic diseases

Journal: Clinical and Experimental Pediatrics

Article Title: Development of orphan drugs for rare diseases

doi: 10.3345/cep.2023.00535

Figure Lengend Snippet: FDA/EMA approved gene therapy product for rare monogenic diseases

Article Snippet: For instance, an autologous CD34+-enriched cell fraction, Strimvelis (GlaxoSmithKline plk, London, UK), which contains CD34+ cells transduced with a retroviral vector that encodes the human ADA cDNA sequence for ADA deficiency (introduced in 2016), and voretigene neparvovec-rzyl (Luxturna, Spark Therapeutics, Philadelphia, USA), for retinal dystrophy caused by mutations in the RPE65 gene, were approved by the FDA in 2017 at a cost of $850,000 per eye [ ].

Techniques: Plasmid Preparation, In Vivo, Ex Vivo, Mutagenesis, Modification, Variant Assay